Akela Pharma Inc. — Investor Relations & Filings
Akela Pharma Inc. is an integrated drug development company focused on creating therapeutics for the pain and inhalation markets. The company leverages proprietary drug delivery technologies to develop pharmaceutical preparations targeting disorders of the respiratory and central nervous systems. A significant operational component is PharmaForm, a wholly owned subsidiary. PharmaForm functions as a specialty contract service provider, offering comprehensive expertise in pharmaceutical dosage form development, formulation research and development, and related pre-clinical and clinical services. Key historical developments include the licensing of the Fentanyl TAIFUN(R) system. The company has strategically prioritized its profitable contract services division.
Recent filings
No filings indexed yet
We are still gathering filings for Akela Pharma Inc.. .
No filings match the current filters
Try clearing the filters, or .
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Take Solutions Ltd
Provides specialized domain-led technology and services for…
|
TAKE | IN | Professional, scientific and te… |
|
Tango Therapeutics, Inc.
A clinical-stage biotech developing precision oncology medi…
|
TNGX | US | Professional, scientific and te… |
|
Taysha Gene Therapies, Inc.
Clinical-stage company developing AAV-based gene therapies …
|
TSHA | US | Professional, scientific and te… |
|
Technical Ventures RX Corp.
Develops and commercializes autologous cell therapies for t…
|
— | CA | Professional, scientific and te… |
|
Tectonic Therapeutic, Inc.
Clinical-stage biotech developing biologics targeting G-Pro…
|
TECX | US | Professional, scientific and te… |
|
Telo Genomics Corp.
Quantifies genomic instability via telomere 3D structure to…
|
TELO | CA | Professional, scientific and te… |
|
Telomir Pharmaceuticals, Inc.
Pre-clinical pharma company developing a small molecule for…
|
TELO | US | Professional, scientific and te… |
|
Tempest Therapeutics, Inc.
Clinical-stage oncology company developing small molecule a…
|
TPST | US | Professional, scientific and te… |
|
Terns Pharmaceuticals, Inc.
Clinical-stage biopharma developing small-molecule drugs fo…
|
TERN | US | Professional, scientific and te… |
|
TERRAGEN HOLDINGS LIMITED
Develops microbial technology to enhance animal health and …
|
TGH | US | Professional, scientific and te… |
Akela Pharma Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/43160/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=43160 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=43160 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=43160 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 43160}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Akela Pharma Inc. (id: 43160)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.